NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Epidemiology: Epilepsy

http://www.reportlinker.com/p0484937/Epidemiology-Epilepsy.html

Datamonitor has estimated that there were approximately 4.5 million cases of diagnosed active epilepsy in 2010 in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). Almost half of this patient population lives in the US. Datamonitor expects prevalence rates to remain constant over the forecast period (2010–20). As such, the aging populations in thGain insight to market potential, including a robust 10-year epidemiology forecast of prevalent cases of diagnosed active epilepsy. Understand the key epidemiologic risk factors associated with epilepsy. Datamonitor expects an increase in diagnosed active epilepsy cases in the next decade in the seven major markets as a result of an increase in populations. Chronic epilepsy can result in brain damage, disability, and a low quality of life causing high social and economic burden What are the most robust epidemiologic studies for diagnosed active epilepsy prevalence data? How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?How do changes in population structure and risk factors affect the trend in prevalent diagnosed active epilepsy cases?

Executive Summary

Key findings

OVERVIEW

Catalyst

Summary

DISEASE DEFINITION AND DIAGNOSIS CRITERIA

Disease definition

GLOBAL VARIATION AND HISTORICAL TRENDS

Epilepsy prevalence is comparable in the seven major markets, yet different than in the developing world

Prevalence: higher in children and in those with low socioeconomic status

Incidence: decreasing in children while increasing in elderly

Mortality: highest in children

CO-MORBIDITIES

Depression is the common co-morbidity

RISK FACTORS

Idiopathic and cryptogenic are dominant risk factors of epilepsy

Cerebrovascular disease: most common identifiable cause in adults

Head injury: severity dependent

Central nervous system infection and tumors: cysticercosis is the most common

Perinatal factors: most prevalent in developing countries

Other factors: family history and alcohol

EPIDEMIOLOGIC FORECASTING OF EPILEPSY

Overview

US

Sources used

Methods

Japan

Sources used

Methods

France

Sources used

Methods

Germany

Sources used

Italy

Sources used

Methods

Spain

Sources used

Methods

UK

Sources used

Methods

EPIDEMIOLOGIC RESULTS

Current prevalent cases and future trends

DISCUSSION

Strengths and limitations of our epidemiologic projections

Conclusions

BIBLIOGRAPHY

Journal papers

Websites

APPENDIX A

Report methodology

To order this report:

: Epidemiology: Epilepsy

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker